Showing results (11-20 of 36) with videos related to

Sort By:
Pageof 4
Proceedings of the National Academy of Sciences of the United States of America|November 23, 2005
Inactivation of the Snf5 tumor suppressor stimulates cell cycle progression and cooperates with p53 loss in oncogenic transformationMichael S Isakoff, Courtney G Sansam, Pablo Tamayo, et al.
Pediatric Blood & Cancer|November 1, 2018
A phase II study of eribulin in recurrent or refractory osteosarcoma: A report from the Children's Oncology GroupMichael S Isakoff, Robert Goldsby, Doojduen Villaluna, et al.
Pediatric Blood & Cancer|May 10, 2020
Phase II trial of gemcitabine and nab-paclitaxel in patients with recurrent Ewing sarcoma: A report from the National Pediatric Cancer FoundationJavier E Oesterheld, Damon R Reed, Bhuvana A Setty, et al.
European Journal of Cancer (Oxford, England : 1990)|May 14, 2013
Feasibility and dose discovery analysis of zoledronic acid with concurrent chemotherapy in the treatment of newly diagnosed metastatic osteosarcoma: a report from the Children's Oncology GroupRobert E Goldsby, Timothy M Fan, Doojduen Villaluna, et al.
Cancer|July 5, 2023
Consensus recommendations in the management of Ewing sarcoma from the National Ewing Sarcoma Tumor BoardAjay Gupta, Richard F Riedel, Chirag Shah, et al.
Pediatric Blood & Cancer|September 15, 2017
Consensus and controversies regarding the treatment of rhabdomyosarcomaScott C Borinstein, Diana Steppan, Masanori Hayashi, et al.
Cancer Medicine|December 31, 2015
Pediatric phase I trial of oral sorafenib and topotecan in refractory or recurrent pediatric solid malignanciesDamon R Reed, Leo Mascarenhas, Kathleen Manning, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 14, 2022
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar RhabdomyosarcomaGiselle Saulnier-Sholler, Dan G Duda, Genevieve Bergendahl, et al.
European Journal of Cancer (Oxford, England : 1990)|July 9, 2022
Phase 2 study of anti-disialoganglioside antibody, dinutuximab, in combination with GM-CSF in patients with recurrent osteosarcoma: A report from the Children's Oncology GroupPooja Hingorani, Mark Krailo, Allen Buxton, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 26, 2023
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome ComparisonsJavier Oesterheld, William Ferguson, Jacqueline M Kraveka, et al.
Pageof 4